ABSTRACT Background: B-chronic-lymphocytic-leukemia (B-CLL) is a heterogeneous
illness with a varied clinical history. Some individuals don't require therapy while others …

Background Clinical variability in chronic lymphocytic leukemia with progress from indolent,
withnoneedoftreatment, toaggressive, withshortmorbidityandsurvival, still remains unclear …

Introduction: Amongst all chronic lymphoproliferative disorders B-CLL is the most common.
Clinical behavior of CLL is very variable and in order to identify the clinical spectrum there is …

This study aimed to determine the prognostic impact of CD69 expression in B cell chronic
lymphocytic leukemia (CLL). The study included 153 B cell chronic lymphocytic leukemia (B …

Background: Increased proliferation and survival of leukemic B-lymphocytes can be induced
by CD69 overexpression, which resembles B cells at an earlier and larger stage of …

Objective: To find out the frequency of ZAP-70, CD38 and CD49d in patients diagnosed with
CLL in our population. Methods: This is a cross sectional study conducted in Army Medical …

Chronic lymphocytic leukemia is one of the most common types of leukemia in adults. It
belongs to the group of indolent lymphoproliferative disorders and has a slow clinical …

The aim of the present study was to investigate different biological prognostic markers to
identify high‑risk patients with chronic lymphocytic leukemia (CLL) with a higher tumor …

CD49d as Prognostic Marker in B-Cell Chronic Lymphocytic Leukemia in Correlation with the
Expression of CD38, ZAP-70 and Clinica Page 1 THE IRAQI POSTGRADUATE MEDICAL …

Introduction Chronic lymphocytic leukemia (CLL) is the commonest hematological
malignancy in the West but is relatively uncommon in India. The prognosis of CLL is …